Seed Funded World First Blood Biomarker for MS Types
Progressive MS research scientific conference held biennially
22 July, 2021

Pharmaceutical company Sanofi have advised that their MS disease modifying therapy Aubagio will be delisted from the Australian market from October 2021.

MSWA funding announcement
21 July, 2021

MS Australia has received a major funding boost of $7.4 million from MSWA, which is the largest single donation received by MS Australia from any donor.

stem cells
19 July, 2021

Australian researchers and disease-based charities are working together to promote and simplify access to evidence-based stem cell therapies in Australia.

The Australian MS Longitudinal Study

The Australian MS Longitudinal Study (AMSLS) is a long-term, survey-based, tracking study collecting data of practical use for improving the lives of Australians living with MS.

MS Research Australia Clinical Trials Network

The MS Research Australia Clinical Trials Network connects trial sponsors and clinical research organisations with potential trial sites, health professionals and people with MS in Australia and New Zealand.

Vitamin D MS Prevention Trial - PrevANZ

The vitamin D MS Prevention Trial is a clinical trial that will test whether vitamin D supplementation can prevent MS in those at risk of developing the disease.

MS Research Australia Brain Bank

The MS Research Australia Brain Bank coordinates the collection, storage and distribution of neurological tissue from people with MS for use in research.

Associate Professor Anthony Don
The Centenary Institute and the University of Sydney, NSW



Professor Jonathon Baell
Monash University, VIC



Dr Malini Visweswaran
St Vincent's Centre of Applied Medical Research, NSW



Dr Claudia Marck
University of Melbourne, VIC




Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search